Pirfenidone suppresses MAPK signalling pathway to reverse epithelial-mesenchymal transition and renal fibrosis

Matrix metalloproteinases and epidermal wound repair

(2012) Vera L. Martins et al.   CELL AND TISSUE RESEARCH

Antifibrotic Effects of Pirfenidone in Rat Proximal Tubular Epithelial Cells

(2012) Koji Takakura et al.   RENAL FAILURE

Rosuvastatin Preserves Renal Structure following Unilateral Ureteric Obstruction in the Neonatal Rat

(2011) Luciana Jorgelina Mazzei et al.   AMERICAN JOURNAL OF NEPHROLOGY

Fibroblasts and myofibroblasts in renal fibrosis

(2011) Soma Meran et al.   INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY

Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials

(2011) Paul W Noble et al.   LANCET

Mechanisms of Tubulointerstitial Fibrosis

(2010) M. Zeisberg et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Renoprotective properties of pirfenidone in subtotally nephrectomized rats

(2009) Koji Takakuta et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Cytokines in Epithelial-Mesenchymal Transition: A New Insight Into Obstructive Nephropathy

(2008) Ahmad H. Bani-Hani et al.   JOURNAL OF UROLOGY

Pirfenidone inhibits the expression of HSP47 in TGF-β1-stimulated human lung fibroblasts

(2007) Seiko Nakayama et al.   LIFE SCIENCES

Epithelial-to-mesenchymal transition and chronic allograft tubulointerstitial fibrosis

(2007) Surmeet Bedi et al.   Transplantation Reviews